Clinical Trial Update: The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating BAT8001 injection for efficacy and safety in HER2-positive advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BAT8001

Snippet

Sponsor: Bio-Thera Solutions | Conditions: HER2-positive Advanced Breast Cancer | Phase 3 | Status: UNKNOWN